Empower Your Model Selection Strategy to Enhance Preclinical Candidate Success
December 4 - 6, 2019
Patient-Derived Experimental Models for Translational Cancer Research
Thursday 5th December, 9:00am
Learn how to advance oncology drug development through using clinically-relevant patient-derived models, including in vivo PDX, and in vitro patient-derived organoids (PDO) and PDX-derived organoids (PDXO). Find out how to adopt the right model for the right study across oncology therapeutics, and how paired models provide a pioneering platform for translational cancer research.